Study on the Effectiveness of EGb 761® vs Placebo Used for Cognitive Impairment in Patients With Multiple Sclerosis
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the use of EGb 761 by patients with
Relapsing-Remitting Multiple Sclerosis is effective in improving cognition, when compared to
placebo.